268 related articles for article (PubMed ID: 25342375)
1. Biologic treatment in Sjögren's syndrome.
Sada PR; Isenberg D; Ciurtin C
Rheumatology (Oxford); 2015 Feb; 54(2):219-30. PubMed ID: 25342375
[TBL] [Abstract][Full Text] [Related]
2. Emerging biological therapies in primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P
Rheumatology (Oxford); 2007 Sep; 46(9):1389-96. PubMed ID: 17586555
[TBL] [Abstract][Full Text] [Related]
3. Biologic treatments in Sjögren's syndrome.
Bowman S; Barone F
Presse Med; 2012 Sep; 41(9 Pt 2):e495-509. PubMed ID: 22836195
[TBL] [Abstract][Full Text] [Related]
4. Emerging biotherapies for Sjögren's syndrome.
Tobón GJ; Saraux A; Pers JO; Youinou P
Expert Opin Emerg Drugs; 2010 Jun; 15(2):269-82. PubMed ID: 20384543
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome: Old and new therapeutic targets.
Mavragani CP; Moutsopoulos HM
J Autoimmun; 2020 Jun; 110():102364. PubMed ID: 31831255
[TBL] [Abstract][Full Text] [Related]
6. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.
Cornec D; Devauchelle-Pensec V; Tobón GJ; Pers JO; Jousse-Joulin S; Saraux A
J Autoimmun; 2012 Sep; 39(3):161-7. PubMed ID: 22749831
[TBL] [Abstract][Full Text] [Related]
7. The future of B cell-targeted therapies in Sjögren's syndrome.
Cornec D; Saraux A; Devauchelle-Pensec V; Clodic C; Pers JO
Immunotherapy; 2013 Jun; 5(6):639-46. PubMed ID: 23725286
[TBL] [Abstract][Full Text] [Related]
8. New biological therapies in Sjögren's syndrome.
Nocturne G; Cornec D; Seror R; Mariette X
Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):783-93. PubMed ID: 27107513
[TBL] [Abstract][Full Text] [Related]
9. Biologics in oral medicine: Sjogren syndrome.
O'Neill ID; Scully C
Oral Dis; 2013 Mar; 19(2):121-7. PubMed ID: 22497865
[TBL] [Abstract][Full Text] [Related]
10. Use of Biologics in Sjögren's Syndrome.
Nocturne G; Cornec D; Seror R; Mariette X
Rheum Dis Clin North Am; 2016 Aug; 42(3):407-17. PubMed ID: 27431344
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab.
Devauchelle-Pensec V; Cagnard N; Pers JO; Youinou P; Saraux A; Chiocchia G
Arthritis Rheum; 2010 Aug; 62(8):2262-71. PubMed ID: 20506202
[TBL] [Abstract][Full Text] [Related]
12. Present and future of biologic drugs in primary Sjögren's syndrome.
Sambataro D; Sambataro G; Dal Bosco Y; Polosa R
Expert Opin Biol Ther; 2017 Jan; 17(1):63-75. PubMed ID: 27616561
[TBL] [Abstract][Full Text] [Related]
13. B cell-targeted therapies in Sjögren's syndrome.
Tobón GJ; Pers JO; Youinou P; Saraux A
Autoimmun Rev; 2010 Feb; 9(4):224-8. PubMed ID: 19671451
[TBL] [Abstract][Full Text] [Related]
14. Biologic treatments for systemic rheumatic diseases.
Shirota Y; Illei GG; Nikolov NP
Oral Dis; 2008 Apr; 14(3):206-16. PubMed ID: 18282173
[TBL] [Abstract][Full Text] [Related]
15. The management of Sjögren's syndrome.
Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
[TBL] [Abstract][Full Text] [Related]
16. Biologic therapies in primary Sjögren's syndrome.
Bowman SJ
Curr Pharm Biotechnol; 2012 Aug; 13(10):1997-2008. PubMed ID: 22208654
[TBL] [Abstract][Full Text] [Related]
17. Biologics in Sjögren's syndrome.
Skarlis C; Marketos N; Mavragani CP
Pharmacol Res; 2019 Sep; 147():104389. PubMed ID: 31415917
[TBL] [Abstract][Full Text] [Related]
18. Primary Sjogren's syndrome: current and prospective therapies.
Thanou-Stavraki A; James JA
Semin Arthritis Rheum; 2008 Apr; 37(5):273-92. PubMed ID: 17714766
[TBL] [Abstract][Full Text] [Related]
19. SER recommendations on the use of biological drugs in primary Sjögren's syndrome.
Andréu Sánchez JL; Fernández Castro M; Del Campo Fontecha PD; Corominas H; Narváez García FJ; Gómez de Salazar JR; Rua-Figueroa Í; Abad Hernández MÁ; Álvarez Rivas MN; Montes JDP; Francisco Hernández FM; Gantes Pedraza MÁ; Greco Merino MG; Hernández MV; Navarro Compán MV; Solarte JAP; Romero Bueno FI; Park HS; Sivera Mascaró F
Reumatol Clin (Engl Ed); 2019; 15(6):315-326. PubMed ID: 30683506
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential for B-cell modulation in Sjögren's syndrome.
Mariette X
Rheum Dis Clin North Am; 2008 Nov; 34(4):1025-33, x. PubMed ID: 18984420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
